(Q40304345)

19 September 2017

title

Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus (English)

1 reference

19 September 2017

Daniel Vallböhmer

1

1 reference

19 September 2017

Steven R DeMeester

2

1 reference

19 September 2017

Daniel S Oh

3

1 reference

19 September 2017

Farzaneh Banki

4

1 reference

19 September 2017

Hidekazu Kuramochi

5

1 reference

19 September 2017

Daisuke Shimizu

6

1 reference

19 September 2017

Jeffrey A Hagen

7

1 reference

19 September 2017

Kathleen D Danenberg

8

1 reference

19 September 2017

Peter V Danenberg

9

1 reference

19 September 2017

Parakrama T Chandrasoma

10

1 reference

19 September 2017

Jeffrey H Peters

11

1 reference

19 September 2017

Tom R DeMeester

12

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

The American Journal of Gastroenterology

19 September 2017

published in

1 reference

19 September 2017

volume

101

1 reference

19 September 2017

issue

7

1 reference

19 September 2017

page(s)

1458-1466

1 reference

The burden of selected digestive diseases in the United States

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Molecular biology of Barrett's adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Laser capture microdissection: molecular analysis of tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Epidemiology of upper gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Chemoprevention for Barrett's esophagus trial. Design and outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Inflammatory gradient in Barrett's oesophagus: implications for disease complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Aspirin and reduced risk of esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00601.X

10.1111/J.1572-0241.2006.00601.X

21 January 2018

Identifiers

DOI

1 reference

release_ntuzofszlrczpinic2dht32c7u

19 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ntuzofszlrczpinic2dht32c7u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference